Summary

Overview
Global Intrapartum Monitoring Devices Market reached US$ XX million in 2023 and is expected to reach US$ XX million by 2031, growing at a CAGR of XX% during the forecast period 2024-2031.
Intrapartum monitoring devices are specialised medical devices used for tracking the temporal association between fetal heart rate (FHR) and uterine contractions during labour and delivery. These devices monitor the changes in FHR with the help of Doppler ultrasound or a direct fetal scalp electrode, and they also monitor uterine contractions using transducers. Intrapartum monitoring devices have been proven effective in reducing complications during childbirth, such as brain damage, cerebral palsy, newborn seizures, or fetal death.
Market Dynamics: Drivers & Restraints
Rise in technological advancements
The continuous improvement in intrapartum monitoring devices is resulting in better patient outcomes. The companies are also benefiting in terms of reduced operational costs. The growing demand for better products by consumers is driving the market players to focus on innovation for developing advanced products as per the consumer demand. The use of Artificial Intelligence is further transforming the market. The government & Industry leaders are investing in the research on the adoption of Al to reduce the risk of intrapartum stillbirths.
For instance, in February 2023, The Texas Children's Hospital partnered with Baylor's Children Foundation to support the adoption of intrapartum monitoring using artificial intelligence under the maternal neonatal health project under the hospital. The project has reported success with Al-based intrapartum monitoring. Al proved instrumental in monitoring & identifying the risks at the rise time reducing stillbirths.
Furthermore, global intrapartum monitoring devices are also driven by various other factors like an increasing risk of childbirth complications, government initiatives and regulations and others helping the market to grow during the forecast period.
High costs associated with the devices
High costs are a significant challenge in the intrapartum monitoring devices market, which can limit the adoption of advanced devices in certain regions. Concerns regarding data privacy and security also pose challenges, as these devices involve sensitive patient information. Also, Limited awareness and infrastructure in low-income regions can hinder market growth, highlighting the need for continuous research and development to introduce innovative products that cater to specific needs.
Segment Analysis
The global intrapartum monitoring devices market is segmented based on product type, application, end-user and region.
The electrodes from the product type segment accounted for approximately 42.3% of the intrapartum monitoring devices market share
The electrodes from the product type segment accounted for approximately 42.3%. The electrodes are further segmented into an intrauterine pressure catheter, a transducer for fetal heart rate, a transducer for uterine contractions and fetal scalp electrodes. The electrodes in intrapartum monitoring are either externally attached or minimally invasive for monitoring.
The high growth of the electrodes is attributed to their higher adoption rates, rising preterm births, and increasing diabetes cases in women. According to the International Diabetes Federation, 1 in 6 births was affected by gestational diabetes in 2019. Hence, the rising cases of gestational diabetes mellitus lead to high demand for these monitoring devices and are expected to drive the market in the forecast period.
Geographical Analysis
North America is estimated to hold about 38.4% of the total market share throughout the forecast period
North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to factors like the rising prevalence of gynecological diabetes mellitus, and growing cases of obesity. The women suffering from gynecological diabetes mellitus are also prone to intrapartum issues and preterm deliveries. Moreover, novel product launches, FDA approvals advancements help the region to grow during the forecast period.
For instance, in February 2024, GE HealthCare obtained the US Food and Drug Administration (FDA) 510(k) clearance for its Novii+ wireless patch, a wireless maternal and fetal monitoring solution.
Novii+ is a patch-based antepartum and intrapartum monitor that uses non-invasive methods to measure fetal heart rate, maternal heart rate, and uterine activity. The solution provides this information to care teams to have a real-time view of patient data.
Covid 19 Impact Analysis
The COVID-19 pandemic has significantly impacted the medical devices industry, including the intrapartum devices market. The increased demand for personal protective equipment (PPE), ventilators, and other hospital supplies has led to growth in certain therapy areas, such as hospital supplies, anaesthesia and respiratory (A&R) devices, and in vitro diagnostics. However, other areas like diagnostic imaging, cardiovascular devices, and general surgery devices decreased in 2020 due to the postponement of various procedures.
Market Segmentation
By Product Type
• Electrodes
o Fetal Scalp Electrodes
o Intrauterine Pressure Catheters
o Transducer for Fetal Heart Rate
o Transducer for Uterine Contractions
• Monitors
By Application
• Pregnancy Monitoring
• Labor Monitoring
• Delivery Monitoring
By End User
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include GE Healthcare, Koninklijke Philips N.V, CooperSurgical, Inc., MindChild Medical Inc., Edan Instruments, Inc., Soma Technology, Inc., Huntleigh Corporation, Neoventa, Creative Medical Systems, OB Medical Company among others.
Key Developments
 In March 2021 CooperSurgical announced the acquisition of Safe Obstetric Systems, inventor of the patented single-use device, the Fetal Pillow. The Fetal Pillow is designed to elevate a deeply impacted fetal head without injury during a fully dilated C-section (CSFD). With elevated rates of maternal morbidity and mortality, there is an increased focus on reducing maternal and fetal complications during delivery. In technically challenging clinical situations such as CSFD, the use of the Fetal Pillow may reduce maternal blood transfusion.
Why Purchase the Report?
• To visualize the global intrapartum monitoring devices market segmentation based on product type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analysing trends and co-development.
• Excel data sheet with numerous data points of the intrapartum monitoring devices market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global intrapartum monitoring devices market report would provide approximately 64 tables, 61 figures and 186 pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in the technological advancements
4.1.1.2. Rise in the birth rates
4.1.2. Restraints
4.1.2.1. High cost associated with the devices
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. PESTLE Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Electrodes *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Monitors
8. By Application
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Pregnancy Monitoring *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Labor Monitoring
8.4. Delivery Monitoring
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Clinics
9.4. Ambulatory Surgical Centers
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. South Korea
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. GE Healthcare*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Koninklijke Philips N.V
12.3. CooperSurgical, Inc
12.4. MindChild Medical Inc
12.5. Edan Instruments, Inc
12.6. Soma Technology, Inc
12.7. Huntleigh Corporation
12.8. Neoventa
12.9. Creative Medical Systems
12.10. OB Medical Company
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us